Press monitoring
\'Jaws\' may help humans grow new teeth, shark study suggests
15.2.2016 | Press monitoring
A new insight into how sharks regenerate their teeth, which may pave the way for the development of therapies to help humans with tooth loss, has been discovered by scientists at the University of Sheffield. The study has identified a network of genes that enables sharks to develop and regenerate their teeth throughout their lifetime. The genes...
Hepatitis virus-like particles as potential cancer treatment
12.2.2016 | Press monitoring
UC Davis researchers have developed a way to use the empty shell of a Hepatitis E virus to carry vaccines or drugs into the body. The technique has been tested in rodents as a way to target breast cancer, and is available for commercial licensing through UC Davis Office of Research. Hepatitis E virus is feco-orally transmitted, so it can survive...
Sandoz advances its biosimilars program with EMA acceptance of regulatory submission for biosimilar pegfilgrastim
11.2.2016 | Press monitoring
Holzkirchen, 11 February, 2016 - Sandoz, a Novartis company and the global leader in biosimilars, announced today that the European Medicines Agency (EMA) has accepted their Marketing Authorization Application (MAA) for its biosimilar to Amgen's EU-licensed Neulasta ®* (pegfilgrastim) - a long-acting recombinant human granulocyte...
From allergens to anodes: Pollen derived battery electrodes
10.2.2016 | Press monitoring
Pollens, the bane of allergy sufferers, could represent a boon for battery makers: Recent research has suggested their potential use as anodes in lithium-ion batteries. "Our findings have demonstrated that renewable pollens could produce carbon architectures for anode applications in energy storage devices," said Vilas Pol, an associate...
First Patient Treated with Medtronic Valiant TAAA Stent Graft System in Thoracoabdominal Aortic Aneurysm Study
9.2.2016 | Press monitoring
DUBLIN and SIOUX FALLS, S.D. - February 9, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services and solutions and Sanford Health, one of the nation's largest health care systems, today announced the first patient enrolled in a clinical study using the Medtronic Valiant® TAAA Stent Graft System for minimally invasive...
Researchers sequence bedbug genome, find unique features
8.2.2016 | Press monitoring
Purdue University researchers participated in a multi-institute project that sequenced the genome of the common bedbug, a blood-sucking insect that has reemerged globally as a hardy pest capable of withstanding most major classes of insecticides. The genome of Cimex lectularius uncovers the genetic underpinning of bedbugs' unique biology and...
Medtronic First to Receive FDA Approval for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators
5.2.2016 | Press monitoring
DUBLIN - Feb. 5, 2016 - Medtronic plc (NYSE:MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the first and only magnetic resonance imaging (MRI) conditional cardiac resynchronization therapy defibrillators (CRT-Ds) for the treatment of heart failure. The Medtronic Amplia MRI(TM) Quad CRT-D SureScan®...
New detection method for Goby fish invasion
5.2.2016 | Press monitoring
Ponto-Caspian gobies are a flock of five invasive fish species that have colonized freshwaters and brackish waters in Europe and North America. One of them, the round goby Neogobius melanostomus, figures among the 100 worst invaders in Europe. Current methods to detect the presence of Ponto-Caspian gobies involve catching or sighting the fish....
Biologist\'s gene-editing kit lets do-it-yourselfers play God at the kitchen table
3.2.2016 | Press monitoring
On the kitchen table of his cramped apartment, Josiah Zayner is performing the feat that is transforming biology. In tiny vials, he's cutting, pasting and stirring genes, as simply as mixing a vodka tonic. Next, he slides his new hybrid creations, living in petri dishes, onto a refrigerator shelf next to the vegetables. And he's packaging and...
Sanofi Pasteur to leverage its strong vaccine legacy in hunt for Zika vaccine
2.2.2016 | Press monitoring
Lyon, France - February 2, 2016 - Sanofi Pasteur , the vaccines division of Sanofi , announced today that it has launched a vaccine research and development project targeting the prevention of Zika virus infection and disease.
